All In MedTech

Device Trial Radar · NCT01510392

CEI Van Outreach Screening Study

Prospective Evaluation of Optical Coherence Tomography Usage in the Screening of Eye Diseases

Last checked: Nov 19, 2026Latest source record: Apr 12, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

118

Actual

Start

Jan 2012

Primary completion

Feb 2, 2017

Study completion Feb 2, 2017

Sponsor

Lead sponsor
Oregon Health and Science UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Eye Institute (NEI)
First posted
Jan 16, 2012

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years, up to 89 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The primary goal of the trial is to show that optical coherence tomography (OCT) technology can be used to effectively screen for diseases of the eye including glaucoma, macular diseases and keratoconus. Glaucoma is a disease that causes permanent vision loss and is usually accompanied by increased eye pressure. Macular diseases affect sharp, central vision. Keratoconus is a disease that affects the cornea (clear surface covering the colored part of the eye).

Conditions

  • Glaucoma
  • Macular Disease
  • Keratoconus

Interventions

  • OCT imaging, the FDA Cleared iVueDevice

    The OCT system scans a beam of light across the eye to take a picture. OCT imaging does not touch the eye. This is a test that is performed using an FDA approved system, and is regularly used to take pictures of the back of the eye.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. OCT screening efficacy for detection of early stage eye diseases in comparison to the current standard of care methodsTime frame: 1 year

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Casey Eye Institute Outreach Screening Van

    Portland, Oregon

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.